首页> 美国卫生研究院文献>Journal of Clinical Microbiology >Detection of Methicillin-Resistant Staphylococcus aureus Directly from Nasal Swab Specimens by a Real-Time PCR Assay
【2h】

Detection of Methicillin-Resistant Staphylococcus aureus Directly from Nasal Swab Specimens by a Real-Time PCR Assay

机译:实时PCR检测直接从鼻拭子样本中检测耐甲氧西林的金黄色葡萄球菌

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Screening for colonization with methicillin-resistant Staphylococcus aureus (MRSA) is a key aspect of infection control to limit the nosocomial spread of this organism. Current methods for the detection of MRSA in clinical microbiology laboratories, including molecularly based techniques, require a culture step and the isolation of pure colonies that result in a minimum of 20 to 24 h until a result is known. We describe a qualitative in vitro diagnostic test for the rapid detection of MRSA directly from nasal swab specimens (IDI-MRSA; Infectio Diagnostic, Inc., Sainte-Foy, Québec, Canada), based upon a real-time PCR and direct detection of MRSA via amplicon hybridization with a fluorogenic target-specific molecular beacon probe. Samples from 288 patients were analyzed for the presence of MRSA with the IDI-MRSA assay, compared to detection by either direct plating or enrichment broth selective culture methods. The diagnostic values for this MRSA screening method were 91.7% sensitivity, 93.5% specificity, 82.5% positive predictive value, and 97.1% negative predictive value when compared to culture-based methods. The time from the start of processing of specimen to result was approximately 1.5 h. In our hands, the IDI-MRSA assay is a sensitive and specific test for detection of nasal colonization with MRSA and providing for same-day results, allowing more efficient and effective use of infection control resources to control MRSA in health care facilities.
机译:用耐甲氧西林的金黄色葡萄球菌(MRSA)进行定殖筛选是控制感染以限制该生物体在医院内传播的关键方面。当前临床微生物学实验室中检测MRSA的方法,包括基于分子的技术,需要培养步骤和纯菌落的分离,至少需要20到24小时才能分离出已知结果。我们描述了一种基于实时PCR和直接检测方法的定性体外诊断测试,用于直接从鼻拭子样本(IDI-MRSA; Infectio Diagnostic,Inc.,Sainte-Foy,魁北克,加拿大)中直接检测MRSA。通过与荧光靶标特异性分子信标探针的扩增子杂交进行MRSA。与通过直接平板或富集培养液选择性培养方法进行检测相比,使用IDI-MRSA分析法分析了288例患者的样品中是否存在MRSA。与基于培养的方法相比,此MRSA筛选方法的诊断价值为91.7%的敏感性,93.5%的特异性,82.5%的阳性预测值和97.1%的阴性预测值。从开始处理样品到得到结果的时间约为1.5小时。在我们手中,IDI-MRSA检测是一种灵敏而特异性的检测,用于检测MRSA鼻腔定植并提供当日结果,从而可以更有效地利用感染控制资源来控制卫生保健机构中的MRSA。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号